Nuclear Insulin-Like Growth Factor Binding Protein-3 As a Biomarker in Triple-Negative Breast Cancer Xenograft Tumors: Effect of Targeted Therapy and Comparison With Chemotherapy by Sohel M. Julovi, Janet L. Martin, Robert C. Baxter

Get full text

Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Ductal Adenocarcinoma by Matthew H. Wong, Aiqun Xue, Robert C. Baxter, Nick Pavlakis, Ross C. Smith

Get full text

Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade by Janet L. Martin, Sohel M. Julovi, Mike Z. Lin, Hasanthi C. de Silva, Frances M. Boyle, Robert C. Baxter

Get full text

Displacement of Native FXYD Protein From Na+/K+-ATPase With Novel FXYD Peptide Derivatives: Effects on Doxorubicin Cytotoxicity by Chia-Chi Liu, Yeon Jae Kim, Rachel Teh, Alvaro Garcia, Elisha J. Hamilton, Flemming Cornelius, Robert C. Baxter, Helge H. Rasmussen, Helge H. Rasmussen

Get full text

Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3. by Yagna P R Jarajapu, Jun Cai, Yuanqing Yan, Sergio Li Calzi, Jennifer L Kielczewski, Ping Hu, Lynn C Shaw, Sue M Firth, Tailoi Chan-Ling, Michael E Boulton, Robert C Baxter, Maria B Grant

Get full text

Limitations of galactose therapy in phosphoglucomutase 1 deficiency by Kristine Nolting, Julien H. Park, Laura C. Tegtmeyer, Andrea Zühlsdorf, Marianne Grüneberg, Stephan Rust, Janine Reunert, Ingrid Du Chesne, Volker Debus, Eric Schulze-Bahr, Robert C. Baxter, Yoshinao Wada, Christian Thiel, Emile van Schaftingen, Ralph Fingerhut, Thorsten Marquardt

Get full text